Bioscience Careers

April 29, 2016

“Career Transitions in the Biological Sciences; Navigating between Academia and Biotech”

Thursday, May 19, 2016 5:30pm-6:30pm in Orin Smith Auditorium, South Lake Union (SLU) Ruwanthi Gunawardane, Ph.D. Director, Stem Cells & Gene Editing Allen Institute of Cell Science, Seattle, WA Ruwanthi (Ru) Gunawardane is part of a multi-disciplinary team focused on building image-based models of cellular behavior. Ru joined the Allen Institute after spending 5 years at

April 15, 2016

“Building a Bright Career through Innovation”

Thursday, May 5, 2016 5pm-6pm in HSB T-747 Lee Weng, Ph.D., MBA Chief Strategy Officer and Board Director Kolo Medical, San Jose, CA To view a video of the panel: click here To view slides of the panel: click here   Looking at the current, highly competitive business landscape, many students may wonder how to start a new career

March 8, 2016

“From Ph.D. to Patent Law”

Thursday, March 31, 2016 5pm-6pm in HSB T-747 Connie Cheng, Ph.D. Patent Agent Wilson Sonsini Goodrich & Rosati, Seattle, WA To view a video of the panel: click here Patent law offers exciting career opportunities for scientists who would like to step outside the lab but still stay involved with cutting-edge technologies. As a patent agent

January 28, 2016

“On the Path to a Diagnosis”

Thursday, February 18, 2016 5pm-6pm in HSB T-747 Lee Kaplan, Ph.D., FACMG, CC, ASCP(CG)CM Director of Cytogenetics BayCare Laboratories, LLC, Tampa, FL To view a video of the panel: click here Lee is a PhD Clinical Cytogeneticist who is passionate about helping patients and physicians reach a diagnosis. She works in the prenatal, pediatric, and oncology

December 16, 2015

“Working in Small Company Biotech”

Thursday, January 28, 2016 5:30pm-6:30pm at South Lake Union in the Orin Smith Auditorium Mark Branum, Ph.D. Director Theraclone Sciences, Seattle, WA To view a video of the panel: click here Mark is a Ph.D. Biochemist with an industry career focused in small company biotech. He is currently a Director at Theraclone Sciences focused on immune-oncology, previously Mark was